Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

American Journal of Surgery

Volumn 179, Issue 5, 2000, Pages 367-371

  Nukui, Yuji ^a   Picozzi, Vincent J ^a   Traverso, L William ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034656872     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(00)00369-X     Document Type: Article

References (15)

1. van Heerden J.A., ReMine W.H., Weiland L.H., et al. Total pancreatectomy for ductal adenocarcinoma of the pancreas. Am J Surg. 142:1981;308-311.
2. Warren K.W., Christophi C., Armendariz R., et al. Current trends in the diagnosis and treatment of carcinoma of the pancreas. Am J Surg. 145:1983;813-818.
3. Jones B.A., Langer B., Taylor B.R. Periampullary tumors which ones should be resected? Am J Surg. 149:1985;46-52.
4. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 59:1987;2006-2010.
5. Foo M.L., Gunderson L.L., Nagorney D.M., et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracil. Int J Radiat Oncol Biol Phys. 26:1993;483-489.
6. Spitz F.R., Abbruzzese J.L., Lee J.E., et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 15:1997;928-937.
7. Yeo C.J., Abrams R.A., Grochow L.B., et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma postoperative adjuvant chemoradiation improves survival . Ann Surg. 225:1997;621-636.
8. Whittington R., Bryer M.P., Haller D.G., et al. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Rad Oncol Biol Phys. 21:1991;1137-1143.
9. Kurzrock R., Talpaz M., Gutterman J.U. Interferons clinical applications . DeVita V.T., Hellman S., Rosenberg S.A. Biologic Therapy of Cancer. 1991;334-348 JB Lippincott, Philadelphia.
10. Holsti L.R., Mattson K., Niiraven A., et al. Enhancement of radiation effects by alpha-interferon in the treatment of small cell lung cancer. Int J Radiat Oncol Biol Phys. 13:1987;1161-1166.
11. Vokes E.E. The promise of biochemical modulation in combined modality therapy. Semin Oncol. 21:1994;29-33.
12. Posner M.C., Gooding W.E., Landreneau R.J., et al. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Cancer J Sci Am. 4:1998;237-246.
13. Kaplan E., Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
14. Klinkenbijl J.H., Jeekel J., Sahmound T., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Ann Surg. 230:1999;776-784.
15. Borden E.C., Parkinson D. A perspective on the clinical effectiveness and tolerance of interferon-alpha. Semin Oncol. 25:(suppl 1):1998;3-8.